Healthcare Professionals
Please log in for special information and services
AOP Orphan presents latest analysis in Polycythaemia Vera at the Annual Meeting ASH 2021
Mag. Andreas Steiner Group CEO AOP Orphan International AG

"AOP Orphan is the European pioneer in Orphan Diseases unconditionally committed to bringing not only drugs but full treatment support to patients with rare diseases."

Dr. Gunther Krumpl Member of governing board AOP Orphan International AG

"AOP Orphan having international expertise in pharmaceutical and clinical development as well as distribution and marketing of drugs in the rare disease area offers flexible solutions for in- and out-licensing partnerships."

Dr. Rudolf Widmann member of governing board AOP Orphan International AG | Founder

"As a company, we are small enough to be really close to our patients, yet we are large enough to be able to provide them high-quality, personalized customer care."